Artificial Cells and Biomimetic Cells: Intelligent Systems Driving a Paradigm Shift in Drug Discovery and Delivery.

Authors

Mengting Xiang, Boyu Su, Chen Jiang, Tao Sun

Published in

Advanced healthcare materials. Oct 28, 2026. Epub Oct 28, 2026.

Abstract

The convergence of synthetic biology, materials science, and artificial intelligence drives a transformative shift in biopharmaceutical research, advancing from passive drug carriers to intelligent, programmable therapeutics. This review evaluates artificial and biomimetic cells as a framework that connects fundamental biological discovery with clinical translation. It examines five key technological pathways: membrane-engineered artificial cells, membraneless organelle (MLO) systems, multicompartmental artificial cells, protocell communication networks, and virtual cells. These platforms enable precise regulation of drug stability, targeting, biosynthesis, and adaptive responsiveness. Recent progress includes microenvironment-triggered release, logic-gated intercellular communication, and virtual cell-assisted high-throughput screening and toxicity prediction. Despite these advances, challenges remain in scalable manufacturing, long-term stability, and regulatory adaptation. The integration of closed-loop learning, interpretable models, and advanced biomanufacturing will be essential to position artificial and biomimetic cell systems at the forefront of next-generation precision medicine.

PMID:
42952019
Bibliographic data and abstract were imported from PubMed on 29 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.